Auriga Upgrades Myriad Genetics (MYGN) Two Notches as Street Expectations Come Down to More Realistic Levels
Tweet Send to a Friend
Shares of Myriad Genetics (Nasdaq: MYGN) are trading at $18.99, up $0.65 (+3.54%) with no significant news releases. However, this ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
